MSH|^~\&|NISTEHRAPP|NISTEHRFAC|NISTIISAPP|NISTIISFAC|20200529084727.655-0500||VXU^V04^VXU_V04|NIST-IZ-AD-2.1_Send_V04_Z22|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|NISTEHRFAC|NISTIISFAC
PID|1||90012^^^NIST-MPI-1^MR||Johnson^Mastodon^^^^^L||20000115|F||2054-5^Black or African‚Äê
American^CDCREC|3358 Livingston Ave^^Bozeman^MT^59715^USA^P||^PRN^PH^^^662^4559522|||||||||2186-5^Not Hispanic or Latino^CDCREC||N|1|||||N
PD1|||||||||||02^Reminder/recall - any method^HL70215|N|20200529|||A|19830615|20150604
ORC|RE|4422^NIST-AA-IZ-2|13696^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|||||||NISTEHRFAC^NISTEHRFacility^HL70362|
RXA|0|1|20200529||135^Influenza, high dose seasonal^CVX|0.5|mL^mL^UCUM||01^Historical Record^NIP001||^^^NIST-Clinic-1||||||PMC^Sanofi Pasteur^MVX|||CP|A
RXR|C28161^Intramuscular^NCIT|RD^Right Deltoid^HL70163
OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200529
OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200529|||VXC40^per immunization^CDCPHINVS
OBX|3|CE|69764-9^Document Type^LN|3|88^Influenza (Live, Intranasal)^cdcgs1vis||||||F|||20200529
OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200529||||||F|||20190815
OBX|5|CE|TPG_PAND^Priority Group - Pandemic^99TPG|4|P2020-Flu^Pandemic 2020 - Influenza^99TPG||||||F|||20200529
OBX|6|CE|TPG_POP_GRP^Priority Group - Population Group^99TPG|4|PG01^Deployed \T\ mission essential personnel^99TPG||||||F|||20200529
OBX|7|CE|TPG_TIER^Priority Group - Tier^99TPG|4|T1^Tier 1^99TPG||||||F|||20200529
